Amundi Asset Management US’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Amundi Asset Management US’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	$581K	Sell	7,659 -2,841	-27%	-$214K	﹤0.01%	1306
2020 Q4	$715K	Sell	10,500 -176	-2%	-$11K	﹤0.01%	1254
2020 Q3	$567K	Hold	10,676	–	–	﹤0.01%	1245
2020 Q2	$622K	Sell	10,676 -161	-1%	-$8.65K	﹤0.01%	1228
2020 Q1	$427K	Buy	10,837 +6,850	+172%	+$401K	﹤0.01%	1225
2019 Q4	$237K	Hold	3,987	–	–	﹤0.01%	1434
2019 Q3	$212K	Sell	3,987 -2,913	-42%	-$149K	﹤0.01%	1448
2019 Q2	$353K	Sell	6,900 -27,627	-80%	-$1.29M	﹤0.01%	1402
2019 Q1	$1.79M	Sell	34,527 -214,800	-86%	-$10.4M	﹤0.01%	1111
2018 Q4	$9.81K	Buy	249,327 +144,876	+139%	+$6.73M	0.01%	662
2018 Q3	$5.38M	Buy	104,451 +98,851	+1,765%	+$4.84M	0.01%	881
2018 Q2	$263K	Sell	5,600 -2,027	-27%	-$83.9K	﹤0.01%	1406
2018 Q1	$270K	Buy	+7,627	New	+$299K	﹤0.01%	1338

Other funds holding SYNH

Advent International Boston, Massachusetts $4.24B AUM 4.24% 1-Year Est. Return

THLTP

Thomas H. Lee (THL) Partners Boston, Massachusetts $205M AUM 1.84% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.65B AUM 9.66% 1-Year Est. Return

Amundi Asset Management US's SYNH Position: Q1 2021 in Review

Amundi Asset Management US reduced its Syneos Health, Inc. Class A Common Stock (SYNH) stake by 27% in Q1 2021, selling an estimated $214K and leaving 7,659 shares worth $581K. The position accounts for ﹤0.01% of the portfolio, ranked #1306.

Amundi Asset Management US first reported a position in SYNH in Q1 2018 and has held it in 13 quarters since. The position peaked at $5.38M in Q3 2018. 319 funds tracked by Wall St. Rank hold SYNH as of Q1 2021.

Amundi Asset Management US held 7,659 shares of Syneos Health, Inc. Class A Common Stock worth $581K as of Q1 2021.
Amundi Asset Management US sold 2,841 Syneos Health, Inc. Class A Common Stock shares in Q1 2021, an estimated $214K.
Syneos Health, Inc. Class A Common Stock made up ﹤0.01% of Amundi Asset Management US's portfolio in Q1 2021, its #1306 holding.
Amundi Asset Management US first reported a position in Syneos Health, Inc. Class A Common Stock in Q1 2018 and has held it in 13 quarters since.
Amundi Asset Management US's Syneos Health, Inc. Class A Common Stock position peaked at $5.38M in Q3 2018.
319 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q1 2021.

Based on Amundi Asset Management US's 13F filing for Q1 2021, filed 17 May 2021.